Cardiac forces regulate zebrafish heart valve delamination by modulating Nfat signaling

PLoS Biol. 2022 Jan 14;20(1):e3001505. doi: 10.1371/journal.pbio.3001505. eCollection 2022 Jan.

Abstract

In the clinic, most cases of congenital heart valve defects are thought to arise through errors that occur after the endothelial-mesenchymal transition (EndoMT) stage of valve development. Although mechanical forces caused by heartbeat are essential modulators of cardiovascular development, their role in these later developmental events is poorly understood. To address this question, we used the zebrafish superior atrioventricular valve (AV) as a model. We found that cellularized cushions of the superior atrioventricular canal (AVC) morph into valve leaflets via mesenchymal-endothelial transition (MEndoT) and tissue sheet delamination. Defects in delamination result in thickened, hyperplastic valves, and reduced heart function. Mechanical, chemical, and genetic perturbation of cardiac forces showed that mechanical stimuli are important regulators of valve delamination. Mechanistically, we show that forces modulate Nfatc activity to control delamination. Together, our results establish the cellular and molecular signature of cardiac valve delamination in vivo and demonstrate the continuous regulatory role of mechanical forces and blood flow during valve formation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Embryo, Nonmammalian
  • Endothelium
  • Heart / embryology
  • Heart Valves / abnormalities*
  • Hemodynamics*
  • Hemorheology
  • Mechanical Phenomena
  • Mesoderm
  • NFATC Transcription Factors / genetics
  • NFATC Transcription Factors / metabolism*
  • Zebrafish / embryology*
  • Zebrafish / genetics

Substances

  • NFATC Transcription Factors

Grants and funding

This project has received funding from the ERC under the European Union’s Horizon 2020 research and innovation program: GA N°682938, by the ANR grant ANR-SNF 310030E-164245 and by the grant ANR-10-LABX-0030-INRT, a French State fund managed by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir labeled ANR-10-IDEX-0002-02. RC was supported by the foundation Lefoullon Delalande (2019). HF was supported by the University of Strasbourg (USIAS-2017-097), the Takeda Medical Research Foundation, the Uehara Memorial Foundation, the Cell Science Research Foundation, and JSPS KAKENHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.